Comparing two antibiotics for fever with low white blood cells in children with blood cancer
Treatments studied
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial compares two antibiotics, ciprofloxacin and ceftazidime, to see which works better for treating fever in children with blood cancer who have a high risk of infection due to low white blood cells. The goal is to find the best treatment to help your child recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 0 and 18 years old.
- Your child has a blood cancer, such as leukemia or lymphoma.
- Your child currently has a fever with low white blood cells (called high-risk neutropenic fever).
- Your child has not had an allergic reaction to ciprofloxacin or ceftazidime before.
- Your child's fever is not from a blood transfusion.
- Your child has not taken other antibiotics (except certain preventive ones) in the last 3 days.
- Your child's kidneys and liver are working properly.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking the antibiotic levofloxacin can prevent a first serious infection (febrile neutropenia) in children with ALL during the first weeks of chemotherapy. It aims to keep kids safer during treatment.
This trial tests a better way to use antibiotics for cancer patients who develop a fever after treatment. It aims to improve care and reduce side effects.
This trial tests whether an antibiotic called ceftazidime-avibactam (CAZ-AVI) can help patients with blood cancers who have a fever and very low infection-fighting white blood cells. It may be an option for people whose doctors plan to use this specific antibiotic to treat their fever.
This trial compares two antibiotics (ceftolozane/tazobactam vs. piperacillin/tazobactam) for treating a bloodstream infection in people with blood cancer who have a very low white blood cell count and a fever. The goal is to see which antibiotic works better.
This trial tests whether a single antibiotic (amoxicillin-clavulanate) works as well as a combination of two antibiotics (amoxicillin-clavulanate plus ciprofloxacin) for treating fever caused by chemotherapy in people with blood cancer. It aims to simplify treatment and reduce antibiotic use while still keeping you safe.
This trial tests whether adding a medicine called G-CSF (which helps your body make more white blood cells) to standard antibiotics works better than antibiotics alone for children with fever and low white blood cells caused by cancer treatment.
Hear when a new Neutropenic Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.